What is a compound pharmacy? It’s a licensed pharmacy that prepares customized medications for individual patients rather than dispensing mass-produced, pre-packaged drugs. If you’re starting semaglutide or tirzepatide through a telehealth provider, you’ve probably seen the term and wondered, reasonably, whether it’s safe. Compounding is a real, long-established part of American medicine — it predates modern pharmaceutical manufacturing entirely — but it’s genuinely different from filling a prescription for a brand-name drug, and it’s worth understanding exactly how it’s regulated rather than taking a vague reassurance at face value.
Key Takeaways
- A compound pharmacy is a licensed facility where pharmacists prepare customized medications for a specific patient’s prescription, rather than mass-producing standardized doses.
- Compounded medications, including compounded semaglutide and tirzepatide, are not FDA-approved — no compounded drug ever is, by definition. This doesn’t mean unregulated; it means regulated differently.
- The primary, routine regulator of most compounding pharmacies is the state board of pharmacy where the pharmacy is licensed, not the FDA.
- The FDA’s role is narrower but real: it can inspect compounding pharmacies for “insanitary conditions,” and it sets rules for where the raw active ingredients (bulk drug substances) must come from.
- A major regulatory shift happened in 2025 that changed which patients can legally receive compounded semaglutide and tirzepatide — worth knowing if you’re wondering why this looked different a year or two ago.
- Voluntary accreditation (like PCAB) and adherence to USP sterile-compounding standards are meaningful quality signals to look for, separate from government licensing.
What Is a Compound Pharmacy, Exactly?
A compound pharmacy is staffed by licensed pharmacists trained in compounding — the practice of combining, mixing, or altering ingredients to create a medication tailored to an individual patient’s prescription. This is different from a standard retail pharmacy, which dispenses medications exactly as manufactured by a pharmaceutical company, in the doses and forms the manufacturer produces.
Compounding has a legitimate, decades-old role in medicine that has nothing to do with GLP-1 medications specifically. It’s how a child who can’t swallow pills gets a liquid version of an adult medication, how a patient with an allergy to a dye or preservative in a commercial drug gets the same active ingredient without that additive, and how a patient needing a dose strength that isn’t commercially manufactured gets one prepared specifically for them. For weight-loss treatment, compounding pharmacies most often prepare semaglutide or tirzepatide in a specific concentration or vial size that fits an individual patient’s prescribed dosing schedule.
Who Actually Regulates Compound Pharmacies?
This is the part most explanations get wrong, so it’s worth being precise about it.
State boards of pharmacy are the primary, day-to-day regulator. Compounding pharmacies that prepare patient-specific prescriptions (known as “503A” pharmacies, named for the relevant section of federal law) are licensed and routinely inspected by the pharmacy board of the state where they operate. These boards enforce standards for sterile technique, staff training, facility conditions, and record-keeping, and they’re the regulator a compounding pharmacy answers to in its everyday operations.
The FDA’s role is real, but narrower than “approval.” The FDA does not approve individual compounded medications, and it doesn’t claim to — compounded drugs are prepared for a specific patient rather than mass-manufactured, so they don’t go through the same clinical-trial review process a drug like Wegovy or Zepbound goes through. What the FDA does do:
- It has legal authority to inspect a compounding pharmacy if there’s a concern about “insanitary conditions” — unsafe or unsanitary preparation environments — and these inspections are sometimes conducted jointly with the state board of pharmacy.
- It sets requirements for the bulk active pharmaceutical ingredients (the raw semaglutide or tirzepatide powder, before it’s compounded into a patient’s prescription) used in compounding. Under FDA rules, those bulk substances generally must come from an FDA-registered manufacturing facility and either comply with an official USP/NF quality monograph, be a component of an already FDA-approved drug, or appear on the FDA’s list of substances cleared for compounding use.
- It monitors adverse events reported after the fact, the same postmarket surveillance system (FAERS) that tracks safety issues with FDA-approved drugs.
So the accurate summary is: compounding pharmacies operate under real regulatory oversight — it’s just a state-primary, ingredient-and-facility-focused model, not FDA drug approval. Anyone telling you a compounded medication itself is “FDA-approved” is describing something that, by definition, doesn’t exist.
The 2025 Regulatory Change You Should Know About
For a period of time, pharmacies could compound semaglutide at scale under an FDA exception that applies when an FDA-approved version of a drug is officially in shortage. The FDA declared that shortage resolved in February 2025, and a court challenge to reverse that decision was denied that April, with the compliance grace period for compounders ending in May 2025.
That doesn’t mean compounded semaglutide or tirzepatide became illegal — it means the legal basis narrowed. Today, patient-specific compounding of these medications is generally permitted when a licensed provider documents an individual clinical reason, such as a dosage strength or form that isn’t commercially available, or a patient’s allergy to an inactive ingredient in the FDA-approved product. It’s a fair and reasonable question to ask any provider — including us — how a specific compounded prescription is classified under current rules.
A Semaglutide-Specific Sourcing Issue Worth Knowing
Separate from the shortage-status question, the FDA has published a specific warning that some compounders have substituted semaglutide salt forms — semaglutide sodium or semaglutide acetate — in place of the base semaglutide used in FDA-approved products like Wegovy and Ozempic. The FDA has stated these salt forms are different active ingredients, not established as equivalent in safety or effectiveness to approved semaglutide. It’s a legitimate question to ask any compounding pharmacy directly: is the active ingredient base semaglutide, and how is that verified on each batch?
What Actually Makes a Compound Pharmacy Trustworthy
Since “FDA-approved” isn’t the right bar to measure a compounding pharmacy against, here’s what actually is:
State licensure, verifiable. Every legitimate compounding pharmacy is licensed in the state(s) it operates in, and that license status is checkable through the relevant state board of pharmacy’s public license lookup.
USP compliance. The United States Pharmacopeia sets the technical standards compounding pharmacies are expected to follow — USP <795> for non-sterile preparations and USP <797> for sterile ones, which covers injectable medications like compounded semaglutide and tirzepatide. These standards cover everything from cleanroom air quality to staff garbing and testing procedures.
Voluntary accreditation. Some compounding pharmacies pursue accreditation through organizations like the Pharmacy Compounding Accreditation Board (PCAB), now operated under ACHC. This isn’t a government requirement — it’s optional — but a pharmacy that has gone through it has been independently audited against a stricter standard than the minimum required by law, which is a meaningful signal.
Ingredient sourcing transparency. A pharmacy that can tell you (or your provider) where its active pharmaceutical ingredient comes from, and that it’s sourced from an FDA-registered facility, is operating the way the rules require. Vague answers to this question are a legitimate reason to ask more questions.
Batch testing and potency verification. Reputable compounding pharmacies test finished batches for potency and purity rather than assuming a formula was executed correctly. This matters in practice — quality failures do happen in this industry, which is exactly why this kind of verification is worth asking about rather than assuming.
Why Compounding Can Be a Genuine Advantage — Not Just a Workaround
Personalization is the actual point of compounding, not a marketing framing on top of it. A commercially manufactured drug comes in a fixed set of doses and forms, chosen to work for the largest number of patients efficiently. Compounding allows a licensed provider to prescribe a strength, volume, or preparation that fits an individual patient’s treatment plan more precisely — which is especially relevant for GLP-1 medications, where dosing is gradually titrated upward over weeks and months. It also allows continued access to treatment for patients whose prescribed strength doesn’t line up with what’s commercially available at a given time.
None of this is a substitute for the safety questions above — a compounded medication is only as good as the pharmacy preparing it — but personalization itself is a legitimate clinical reason compounding exists, not just a byproduct of drug shortages.
How Medica Weight Loss Approaches Pharmacy Partnerships
We work with licensed compounding pharmacies and expect them to meet state licensing requirements and follow USP compounding standards for every prescription they fill. Every patient’s dose is prescribed individually by a provider following an in-house medical screening, not filled from a generic template. If you have specific questions about which pharmacy is preparing your prescription or how your specific medication is classified under current compounding rules, your care team can answer that directly — that’s a fair question, and you should feel comfortable asking it.
Frequently Asked Questions
Is compounded semaglutide or tirzepatide FDA-approved? No. No compounded medication is FDA-approved, by definition — compounding pharmacies prepare patient-specific prescriptions rather than going through the FDA’s mass-manufacturing approval process. This applies to every compounding pharmacy in the country, not just ones associated with weight loss.
If it’s not FDA-approved, is it legal and safe? It can be both. Compounding is legal under federal and state law when performed by a licensed pharmacy under the current rules for patient-specific prescriptions, and it’s regulated primarily by state boards of pharmacy, with FDA oversight of ingredient sourcing and facility conditions. Legality and quality still depend on the specific pharmacy involved, which is why sourcing questions matter.
Who inspects compounding pharmacies? Primarily the state board of pharmacy where the pharmacy is licensed. The FDA can also inspect a compounding pharmacy, most often in response to a specific concern about unsanitary conditions, sometimes alongside the state board.
What’s the difference between a 503A and 503B pharmacy? A 503A pharmacy compounds patient-specific prescriptions and is regulated primarily by its state board of pharmacy. A 503B “outsourcing facility” compounds in larger batches without a patient-specific prescription and registers directly with the FDA, following stricter manufacturing-style standards. For more on this distinction and how it applies specifically to GLP-1 medications, see our prescription weight-loss medication safety guide.
Did something change recently with compounded semaglutide? Yes — the FDA resolved the semaglutide shortage in February 2025, which narrowed the legal basis for large-scale compounding. Patient-specific compounding is still permitted today under narrower circumstances, generally tied to an individual clinical need.
What should I ask before trusting a compound pharmacy? Whether it’s state-licensed (and in which state), whether it follows USP <795>/<797> standards, where its active ingredient is sourced from, and whether it’s voluntarily accredited (for example, through PCAB). A pharmacy or provider willing to answer these directly is a good sign.
Does Medica Weight Loss manufacture or compound its own medication? No. Medica Weight Loss does not compound, manufacture, or dispense medication directly — prescriptions are filled by licensed third-party pharmacies, consistent with our compounded medication disclaimer.
The Bottom Line
A compound pharmacy is a licensed facility that prepares personalized medications for individual patients — a real and long-standing part of American healthcare, not a loophole. It is genuinely regulated, just not through FDA drug approval: state boards of pharmacy handle routine oversight, the FDA governs ingredient sourcing and can inspect for unsafe conditions, and voluntary standards like USP compounding guidelines and PCAB accreditation separate higher-quality pharmacies from the rest. Understanding that distinction — rather than assuming “FDA-approved” applies here the way it does to a brand-name drug — is what actually lets you evaluate a compounding pharmacy’s safety accurately. If you want the deeper clinical safety picture, including dosing-error alerts and known quality-control incidents in this industry, our prescription weight-loss medication safety guide covers that in full, and our semaglutide side effects guide explains what that means for what you might actually experience.
This article is for educational purposes only and is not a substitute for professional medical or legal advice.
Sources
- FDA: Compounding and the FDA — Questions and Answers
- FDA: Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act
- FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
- FDA: Alerts on Dosing Errors Associated with Compounded Injectable Semaglutide Products
- Medica Weight Loss Compounded Medication Disclaimer